Literature DB >> 10220375

Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A.

E Stratikos1, P G Gettins.   

Abstract

To determine the location of the proteinase in the covalent serpin-proteinase complex we prepared seven single-cysteine-containing variants of the Pittsburgh variant of the serpin alpha1-proteinase inhibitor, and we labeled each cysteine with the dansyl fluorophore. The dansyl probes were used to determine proximity of the proteinase trypsin in covalent and noncovalent complexes with the serpin, both by direct perturbation and by fluorescence energy transfer from tryptophans in trypsin to dansyl. Large direct effects on dansyl fluorophores were seen for only two positions in covalent complex and one position in noncovalent complex. Distances ranging from <14 A to 64 A were used to severely constrain possible structures for the complex. The structure consistent with both distance constraints and direct perturbations of the dansyl fluorophores placed the proteinase at the distal end of the serpin from the initial docking site. This position for the proteinase requires complete translocation of the proteinase from one end of the serpin to the other and full insertion of the reactive center loop into beta-sheet A to form the kinetically trapped complex. The consequent tight juxtapositioning of serpin and proteinase could explain how distortion of the proteinase active site can occur and hence how many combinations of serpin and proteinase can be inhibited by a common conformational change mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220375      PMCID: PMC21773          DOI: 10.1073/pnas.96.9.4808

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Serpin-protease complexes are trapped as stable acyl-enzyme intermediates.

Authors:  D A Lawrence; D Ginsburg; D E Day; M B Berkenpas; I M Verhamme; J O Kvassman; J D Shore
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

2.  Distortion of the active site of chymotrypsin complexed with a serpin.

Authors:  M I Plotnick; L Mayne; N M Schechter; H Rubin
Journal:  Biochemistry       Date:  1996-06-11       Impact factor: 3.162

3.  Structural change in alpha-chymotrypsin induced by complexation with alpha 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis.

Authors:  E S Stavridi; K O'Malley; C M Lukacs; W T Moore; J D Lambris; D W Christianson; H Rubin; B S Cooperman
Journal:  Biochemistry       Date:  1996-08-20       Impact factor: 3.162

4.  The use of alpha 2-antiplasmin as a model for the demonstration of complex reversibility in serpins.

Authors:  B H Shieh; J Potempa; J Travis
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

5.  Isolation and properties of human plasma alpha-1-proteinase inhibitor.

Authors:  R Pannell; D Johnson; J Travis
Journal:  Biochemistry       Date:  1974-12-17       Impact factor: 3.162

6.  The preparation of anhydro-trypsin and its reactivity with naturally occurring proteinase inhibitors.

Authors:  H Ako; R J Foster; C A Ryan
Journal:  Biochem Biophys Res Commun       Date:  1972-06-28       Impact factor: 3.575

7.  Structural basis for serpin inhibitor activity.

Authors:  H T Wright; J N Scarsdale
Journal:  Proteins       Date:  1995-07

8.  Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition.

Authors:  D A Lawrence; S T Olson; S Palaniappan; D Ginsburg
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

9.  Trypsin complexed with alpha 1-proteinase inhibitor has an increased structural flexibility.

Authors:  G Kaslik; A Patthy; M Bálint; L Gráf
Journal:  FEBS Lett       Date:  1995-08-21       Impact factor: 4.124

10.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.

Authors:  M C Owen; S O Brennan; J H Lewis; R W Carrell
Journal:  N Engl J Med       Date:  1983-09-22       Impact factor: 176.079

View more
  50 in total

1.  Role of Lys335 in the metastability and function of inhibitory serpins.

Authors:  H Im; M H Yu
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

2.  Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.

Authors:  B Gooptu; B Hazes; W S Chang; T R Dafforn; R W Carrell; R J Read; D A Lomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: use of site-specific fluorescent probes of local environment.

Authors:  Marija Backovic; Efstratios Stratikos; Daniel A Lawrence; Peter G W Gettins
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

4.  Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition.

Authors:  M Simonovic; K Volz
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

Review 5.  How do proteins avoid becoming too stable? Biophysical studies into metastable proteins.

Authors:  Lisa D Cabrita; Stephen P Bottomley
Journal:  Eur Biophys J       Date:  2003-09-19       Impact factor: 1.733

6.  How the serpin α1-proteinase inhibitor folds.

Authors:  Klavs Dolmer; Peter G W Gettins
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

7.  Investigation of the binding between pepsin and nucleoside analogs by spectroscopy and molecular simulation.

Authors:  Zhen Li; Zhigang Li; Lingling Yang; Yuanzhe Xie; Jie Shi; Ruiyong Wang; Junbiao Chang
Journal:  J Fluoresc       Date:  2015-02-27       Impact factor: 2.217

8.  Specificity and reactive loop length requirements for crmA inhibition of serine proteases.

Authors:  Lisa D Tesch; Manikanahally P Raghavendra; Tina Bedsted-Faarvang; Peter G W Gettins; Steven T Olson
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

9.  Serpins in unicellular Eukarya, Archaea, and Bacteria: sequence analysis and evolution.

Authors:  Thomas H Roberts; Jorn Hejgaard; Neil F W Saunders; Ricardo Cavicchioli; Paul M G Curmi
Journal:  J Mol Evol       Date:  2004-10       Impact factor: 2.395

10.  Kinetic intermediates en route to the final serpin-protease complex: studies of complexes of α1-protease inhibitor with trypsin.

Authors:  Ashoka A Maddur; Richard Swanson; Gonzalo Izaguirre; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.